Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice

Biochemical and Biophysical Research Communications

Volumn 377, Issue 1, 2008, Pages 12-16

  Ito, Reiko ^a   Kita, Masakazu ^a   Shin Ya, Masaharu ^a   Kishida, Tsunao ^a   Urano, Atsuyo ^b   Takada, Ryusuke ^a   Sakagami, Junichi ^a   Imanishi, Jiro ^a   Iwakura, Yoichiro ^c   Okanoue, Takeshi ^a   Yoshikawa, Toshikazu ^a   Kataoka, Keisho ^a   Mazda, Osam ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Systems Engineering Consultants Co Ltd   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

DSS induced colitis; IL 17; Inflammatory bowel disease

Indexed keywords

DOCUSATE SODIUM; GRANULOCYTE COLONY STIMULATING FACTOR; HAPTOGLOBIN; INTERLEUKIN 17; INTERLEUKIN 17A; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENTERITIS; ENZYME ACTIVITY; MALE; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANIMALS; CHEMOKINE CCL2; COLITIS; DEXTRAN SULFATE; GRANULOCYTE COLONY-STIMULATING FACTOR; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT;

MUS;

EID: 54449102022     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.09.019     Document Type: Article

References (27)

1. Rutgeerts P., Van Assche G., and Vermeire S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 126 (2004) 1593-1610
2. Egger B., Bajaj-Elliott M., MacDonald T.T., Inglin R., Eysselein V.E., and Buchler M.W. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62 (2000) 240-248
3. Melgar S., Karlsson A., and Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G1328-G1338
4. Ito R., Shin-Ya M., Kishida T., Urano A., Takada R., Sakagami J., et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146 (2006) 330-338
5. Korn T., Oukka M., Kuchroo V., and Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin. Immunol. 19 (2007) 362-371
6. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52 (2003) 65-70
7. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183 (1996) 2593-2603
8. Van Kooten C., Boonstra J.G., Paape M.E., Fossiez F., Banchereau J., Lebecque S., et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J. Am. Soc. Nephrol. 9 (1998) 1526-1534
9. Takaya H., Andoh A., Makino J., Shimada M., Tasaki K., Araki Y., et al. Interleukin-17 stimulates chemokine (interleukin-8 and monocyte chemoattractant protein-1) secretion in human pancreatic periacinar myofibroblasts. Scand. J. Gastroenterol. 37 (2002) 239-245
10. Hata K., Andoh A., Shimada M., Fujino S., Bamba S., Araki Y., et al. IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G1035-G1044
11. Nielsen O.H., Kirman I., Rudiger N., Hendel J., and Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 38 (2003) 180-185
12. Zhang Z., Zheng M., Bindas J., Schwarzenberger P., and Kolls J.K. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 12 (2006) 382-388
13. Ogawa A., Andoh A., Araki Y., Bamba T., and Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110 (2004) 55-62
14. Nakae S., Nambu A., Sudo K., and Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171 (2003) 6173-6177
15. Obermeier F., Kojouharoff G., Hans W., Scholmerich J., Gross V., and Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin. Exp. Immunol. 116 (1999) 238-245
16. Hans W., Scholmerich J., Gross V., and Falk W. Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur. Cytokine Netw. 11 (2000) 67-74
17. Uguccioni M., Gionchetti P., Robbiani D.F., Rizzello F., Peruzzo S., Campieri M., et al. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am. J. Pathol. 155 (1999) 331-336
18. Reinecker H.C., Loh E.Y., Ringler D.J., Mehta A., Rombeau J.L., and MacDermott R.P. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108 (1995) 40-50
19. Cai X.Y., Gommoll Jr. C.P., Justice L., Narula S.K., and Fine J.S. Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol. Lett. 62 (1998) 51-58
20. Fossiez F., Banchereau J., Murray R., Van Kooten C., Garrone P., and Lebecque S. Interleukin-17. Int. Rev. Immunol. 16 (1998) 541-551
21. Ouyang W., Kolls J.K., and Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28 (2008) 454-467
22. McAllister F., Henry A., Kreindler J.L., Dubin P.J., Ulrich L., Steele C., et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol. 175 (2005) 404-412
23. Toy D., Kugler D., Wolfson M., Vanden Bos T., Gurgel J., Derry J., et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177 (2006) 36-39
24. Neurath M.F., Fuss I., Kelsall B.L., Stuber E., and Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182 (1995) 1281-1290
25. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203 (2006) 2473-2483
26. Maloy K.J. The Interleukin-23/interleukin-17 axis in intestinal inflammation. J. Intern. Med. 263 (2008) 584-590
27. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., and Elson C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107 (1994) 1643-1652